CDC Appoints Anti-Vaccine Rhetoric Expert as Second in Command
The US Centers for Disease Control and Prevention (CDC) has appointed Dr. Ralph Abraham, a former member of Congress and surgeon general of Louisiana, as its new principal deputy director – a senior role that oversees the agency's day-to-day operations. The appointment, made over the weekend without official announcement, comes at a time when the CDC is already grappling with a power struggle over vaccine policies.
Abraham has a troubling record on vaccines, having promoted debunked claims about their link to autism and autism, as well as the unsubstantiated Tylenol-autism linkage. He also backed ineffective COVID-19 treatments like ivermectin, which aligns him closely with Health Secretary Robert F. Kennedy Jr., a prominent anti-vaccine advocate.
As Louisiana's surgeon general, Abraham ended a campaign to promote childhood vaccinations and failed to alert Louisianans about whooping cough deaths in a timely manner. His record suggests he will be an ally for Kennedy, who has clashed with more restrained officials like FDA Commissioner Marty Makary over vaccine policies.
The appointment raises concerns about the CDC's ability to effectively combat public health threats, particularly those related to vaccines. With confidence in America's public health agencies at an all-time low, Abraham's arrival may further erode trust in the agency's expertise.
In a separate development, the CDC's new role underlines the ongoing struggle over vaccine policies within federal government. As the battle for control of vaccine policy continues, it remains to be seen how the CDC will navigate this challenging landscape.
Meanwhile, there are other global health developments worth noting – including the announcement that a life-saving malaria vaccine is set to become cheaper, with prices dropping from around $4 to just $2.99 per dose.
The US Centers for Disease Control and Prevention (CDC) has appointed Dr. Ralph Abraham, a former member of Congress and surgeon general of Louisiana, as its new principal deputy director – a senior role that oversees the agency's day-to-day operations. The appointment, made over the weekend without official announcement, comes at a time when the CDC is already grappling with a power struggle over vaccine policies.
Abraham has a troubling record on vaccines, having promoted debunked claims about their link to autism and autism, as well as the unsubstantiated Tylenol-autism linkage. He also backed ineffective COVID-19 treatments like ivermectin, which aligns him closely with Health Secretary Robert F. Kennedy Jr., a prominent anti-vaccine advocate.
As Louisiana's surgeon general, Abraham ended a campaign to promote childhood vaccinations and failed to alert Louisianans about whooping cough deaths in a timely manner. His record suggests he will be an ally for Kennedy, who has clashed with more restrained officials like FDA Commissioner Marty Makary over vaccine policies.
The appointment raises concerns about the CDC's ability to effectively combat public health threats, particularly those related to vaccines. With confidence in America's public health agencies at an all-time low, Abraham's arrival may further erode trust in the agency's expertise.
In a separate development, the CDC's new role underlines the ongoing struggle over vaccine policies within federal government. As the battle for control of vaccine policy continues, it remains to be seen how the CDC will navigate this challenging landscape.
Meanwhile, there are other global health developments worth noting – including the announcement that a life-saving malaria vaccine is set to become cheaper, with prices dropping from around $4 to just $2.99 per dose.